BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34177808)

  • 1. The Enigmatic N-Terminal Domain of Proglucagon; A Historical Perspective.
    Conlon JM
    Front Endocrinol (Lausanne); 2021; 12():683089. PubMed ID: 34177808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biological significance of "enteroglucagon." Present status.
    Bataille D; Jarrousse C; Kervran A; Depigny C; Dubrasquet M
    Peptides; 1986; 7 Suppl 1():37-42. PubMed ID: 3529053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
    Kervran A; Blache P; Bataille D
    Endocrinology; 1987 Aug; 121(2):704-13. PubMed ID: 3595539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas.
    Ghatei MA; Uttenthal LO; Bryant MG; Christofides ND; Moody AJ; Bloom SR
    Endocrinology; 1983 Mar; 112(3):917-23. PubMed ID: 6822217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.
    Blache P; Kervran A; Martinez J; Bataille D
    Anal Biochem; 1988 Aug; 173(1):151-9. PubMed ID: 3189794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and sequence of rat oxyntomodulin.
    Collie NL; Walsh JH; Wong HC; Shively JE; Davis MT; Lee TD; Reeve JR
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9362-6. PubMed ID: 7937770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteroglucagon.
    Holst JJ
    Annu Rev Physiol; 1997; 59():257-71. PubMed ID: 9074764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amino acid sequence of porcine glicentin.
    Thim L; Moody AJ
    Peptides; 1981; 2 Suppl 2():37-9. PubMed ID: 7045833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proglucagon processing in porcine and human pancreas.
    Holst JJ; Bersani M; Johnsen AH; Kofod H; Hartmann B; Orskov C
    J Biol Chem; 1994 Jul; 269(29):18827-33. PubMed ID: 8034635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial.
    Perakakis N; Kalra B; Angelidi AM; Kumar A; Gavrieli A; Yannakoulia M; Mantzoros CS
    Metabolism; 2022 Apr; 129():155157. PubMed ID: 35114286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
    Blache P; Kervran A; Bataille D
    Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric inhibitory peptide-like immunoreactivity in glucagon and glicentin cells: properties and origin. An immunocytochemical study using several antisera.
    Sjölund K; Ekelund M; Håkanson R; Moody AJ; Sundler F
    J Histochem Cytochem; 1983 Jun; 31(6):811-7. PubMed ID: 6188783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of glicentin to proglucagon and glucagon in the porcine pancreas.
    Moody AJ; Holst JJ; Thim L; Jensen SL
    Nature; 1981 Feb; 289(5797):514-6. PubMed ID: 7007887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The primary structure of porcine glicentin (proglucagon).
    Thim L; Moody AJ
    Regul Pept; 1981 May; 2(2):139-50. PubMed ID: 6894800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin.
    Holst JJ
    Biochem J; 1982 Dec; 207(3):381-8. PubMed ID: 7165698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic and intestinal processing of proglucagon in man.
    Orskov C; Holst JJ; Poulsen SS; Kirkegaard P
    Diabetologia; 1987 Nov; 30(11):874-81. PubMed ID: 3446554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract.
    Ghatei MA; Uttenthal LO; Christofides ND; Bryant MG; Bloom SR
    J Clin Endocrinol Metab; 1983 Sep; 57(3):488-95. PubMed ID: 6874888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and chemical characterization of glicentin C-terminal hexapeptide in porcine pancreas.
    Yanaihara C; Matsumoto T; Hong YM; Yanaihara N
    FEBS Lett; 1985 Sep; 189(1):50-6. PubMed ID: 4029398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry.
    Varndell IM; Bishop AE; Sikri KL; Uttenthal LO; Bloom SR; Polak JM
    J Histochem Cytochem; 1985 Oct; 33(10):1080-6. PubMed ID: 3900195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut glucagon, enteroglucagon, gut glucagonlike immunoreactivity, glicentin--current status.
    Holst JJ
    Gastroenterology; 1983 Jun; 84(6):1602-13. PubMed ID: 6188645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.